{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:29:44Z","timestamp":1793410184887,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Presbyopia is the age-related deterioration in the ability to focus on close objects. In order to develop a patient-reported outcome (PRO) instrument to assess near vision functioning, the Near Activity Visual Questionnaire (NAVQ) was adapted to incorporate modern technology (e.g. smartphones) and to be appropriate for use in phakic presbyopia, leading to the development of the NAVQ-Presbyopia (NAVQ-P). Additional single-item instruments of near vision correction independence (NVCI), correction preference (NVCP), and vision satisfaction (NVS) were also developed. The study aimed to evaluate the content validity of the NAVQ-P and additional instruments in individuals with phakic presbyopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants in the US (n\u2009=\u200915), Germany (n\u2009=\u200910) and France (n\u2009=\u200910) took part in face-to-face, qualitative, cognitive debriefing interviews. Seven healthcare professionals (HCPs) were also interviewed to assess the clinical relevance of the PRO instruments. Interviews started with open-ended qualitative concept elicitation questioning; participants then completed the PRO instruments on an electronic tablet using a \u201cthink-aloud\u201d process and were asked about their understanding and relevance of each item, instruction, response scale and recall period. Interviews were conducted in two rounds allowing for modifications between rounds.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The participants interpreted the majority of the PRO instruments and recall period correctly and consistently. They were able to select an appropriate response option without difficulty. Minor modifications were made to the PRO instruments based on interview findings. Instruction\/item wording was modified to include reference to use of a magnifying glass, in addition to glasses and contact lenses. Two items were added to assess difficulty with precision tasks (e.g. sewing) and taking longer to adjust from distance to near vision. HCPs confirmed the relevance of the concepts being measured for presbyopia and recommended the addition of an item assessing contrast sensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Developed in accordance with the FDA PRO Guidance, the findings support content validity of the NAVQ-P as a suitable, well-understood instrument of relevant near vision functioning concepts in individuals with phakic presbyopia. The NVCI and additional PRO instruments are appropriate to assess near vision correction independence, correction preference, and vision satisfaction. Future work will assess the psychometric properties of the NAVQ-P and additional PRO instruments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-021-00379-x","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T17:02:36Z","timestamp":1635008556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of the content validity of patient-reported outcome (PRO) instruments developed for use with individuals with phakic presbyopia, including the Near Activity Visual Questionnaire-presbyopia (NAVQ-P) and the near vision correction independence (NVCI) instrument"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-8934","authenticated-orcid":false,"given":"Sarah","family":"Bentley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Findley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Chiva-Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Naujoks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Patalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"issue":"12","key":"379_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archopht.126.12.1731","volume":"126","author":"BA Holden","year":"2008","unstructured":"Holden BA, Fricke TR, Ho SM, Wong R, Schlenther G, Cronj\u00e9 S, Burnett A, Papas E, Naidoo KS, Frick KD (2008) Global vision impairment due to uncorrected presbyopia. Arch Ophthalmol 126(12):1731\u20131739","journal-title":"Arch Ophthalmol"},{"key":"379_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.preteyeres.2018.09.004","volume":"68","author":"JS Wolffsohn","year":"2019","unstructured":"Wolffsohn JS, Davies LN (2019) Presbyopia: effectiveness of correction strategies. Prog Retin Eye Res 68:124\u2013143","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"379_CR3","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0042-6989(98)00239-9","volume":"39","author":"A Glasser","year":"1999","unstructured":"Glasser A, Campbell MC (1999) On the potential causes of presbyopia. Vis Res 39(7):1267\u20131272","journal-title":"Vis Res"},{"key":"379_CR4","first-page":"956","volume":"10","author":"KR Heys","year":"2004","unstructured":"Heys KR, Cram SL, Truscott RJ (2004) Massive increase in the stiffness of the human lens nucleus with age: The basis for presbyopia? Mol Vis 10:956\u2013963","journal-title":"Mol Vis"},{"issue":"6","key":"379_CR5","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1167\/iovs.15-18413","volume":"57","author":"WH Garner","year":"2016","unstructured":"Garner WH, Garner MH (2016) Protein disulfide levels and lens elasticity modulation: applications for presbyopia. Investig Ophthalmol Vis Sci 57(6):2851\u20132863","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"379_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/10255842.2016.1228907","volume":"20","author":"G David","year":"2017","unstructured":"David G, Pedrigi RM, Humphrey J (2017) Accommodation of the human lens capsule using a finite element model based on nonlinear regionally anisotropic biomembranes. Comput Methods Biomech Biomed Engin 20(3):302\u2013307","journal-title":"Comput Methods Biomech Biomed Engin"},{"issue":"7","key":"379_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ceo.12954","volume":"45","author":"H Kandel","year":"2017","unstructured":"Kandel H, Khadka J, Goggin M, Pesudovs K (2017) Impact of refractive error on quality of life: A qualitative study. Clin Exp Ophthalmol 45(7):677\u2013688","journal-title":"Clin Exp Ophthalmol"},{"key":"379_CR8","doi-asserted-by":"crossref","unstructured":"Kandel H, Khadka J, Shrestha MK, Sharma S, Neupane Kandel S, Dhungana P, Pradhan K, Nepal BP, Thapa S, Pesudovs K (2017) Uncorrected and corrected refractive error experiences of Nepalese adults: a qualitative study. Ophthalmic Epidemiol 1\u201315","DOI":"10.1080\/09286586.2017.1376338"},{"key":"379_CR9","unstructured":"Opthalmology American Academy of Ophthalmology (2017) What is presbyopia? https:\/\/www.aao.org\/eye-health\/diseases\/what-is-presbyopia. Accessed 22nd January 2021"},{"issue":"6","key":"379_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/aos.12308","volume":"92","author":"AD Goertz","year":"2014","unstructured":"Goertz AD, Stewart WC, Burns WR, Stewart JA, Nelson LA (2014) Review of the impact of presbyopia on quality of life in the developing and developed world. Acta Ophthalmol 92(6):497\u2013500","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"379_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/archopht.121.11.1577","volume":"121","author":"PJ McDonnell","year":"2003","unstructured":"McDonnell PJ, Lee P, Spritzer K, Lindblad AS, Hays RD (2003) Associations of presbyopia with vision-targeted health-related quality of life. Arch Ophthalmol 121(11):1577\u20131581","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"379_CR12","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1167\/iovs.10-6353","volume":"52","author":"Q Lu","year":"2011","unstructured":"Lu Q, Congdon N, He X, Murthy GV, Yang A, He W (2011) Quality of life and near vision impairment due to functional presbyopia among rural Chinese adults. Investig Ophthalmol Vis Sci 52(7):4118\u20134123","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"379_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/09286586.2012.716896","volume":"19","author":"S Williams","year":"2012","unstructured":"Williams S, Brian G, Toit Rd (2012) Measuring vision-specific quality of life among adults in Fiji. Ophthalmic Epidemiol 19(6):388\u2013395","journal-title":"Ophthalmic Epidemiol"},{"issue":"8","key":"379_CR14","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ophtha.2015.04.014","volume":"122","author":"KD Frick","year":"2015","unstructured":"Frick KD, Joy SM, Wilson DA, Naidoo KS, Holden BA (2015) The global burden of potential productivity loss from uncorrected presbyopia. Ophthalmology 122(8):1706\u20131710","journal-title":"Ophthalmology"},{"issue":"3","key":"379_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jval.2018.09.1627","volume":"21","author":"M Dhariwal","year":"2018","unstructured":"Dhariwal M, Thakker D, Bouchet C, Lemp-Hull J (2018) Global burden of presbyopia: a systematic literature review. Value Health 21(3):274\u2013274","journal-title":"Value Health"},{"issue":"1","key":"379_CR16","doi-asserted-by":"publisher","first-page":"e000453","DOI":"10.1136\/bmjophth-2020-000453","volume":"5","author":"G Sharma","year":"2020","unstructured":"Sharma G, Chiva-Razavi S, Viriato D, Naujoks C, Patalano F, Bentley S, Findley A, Johnson C, Arbuckle R, Wolffsohn J (2020) Patient-reported outcome measures in presbyopia: a literature review. Br Med J Open Ophthalmol 5(1):e000453","journal-title":"Br Med J Open Ophthalmol"},{"key":"379_CR17","doi-asserted-by":"crossref","unstructured":"Paley J (2016) Phenomenology as qualitative research: A critical analysis of meaning attribution. Routledge, UK","DOI":"10.4324\/9781315623979"},{"issue":"1","key":"379_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcrs.2011.07.032","volume":"38","author":"PJ Buckhurst","year":"2012","unstructured":"Buckhurst PJ, Wolffsohn JS, Gupta N, Naroo SA, Davies LN, Shah S (2012) Development of a questionnaire to assess the relative subjective benefits of presbyopia correction. J Cataract Refract Surg 38(1):74\u201379","journal-title":"J Cataract Refract Surg"},{"issue":"7","key":"379_CR19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-list-item national eye institute visual function questionnaire. Arch Ophthalmol 119(7):1050\u20131058","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"379_CR20","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2003.08.021","volume":"110","author":"S Berry","year":"2003","unstructured":"Berry S, Mangione CM, Lindblad AS, McDonnell PJ, Investigators N-RFG (2003) Development of the National Eye Institute refractive error correction quality of life questionnaire: focus groups. Ophthalmology 110(12):2285\u20132291","journal-title":"Ophthalmology"},{"key":"379_CR21","unstructured":"US Food and Drug Administration (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. FDA, Maryland"},{"issue":"9","key":"379_CR22","doi-asserted-by":"publisher","first-page":"e18306","DOI":"10.2196\/18306","volume":"22","author":"JS Wolffsohn","year":"2020","unstructured":"Wolffsohn JS, Leteneux-Pantais C, Chiva-Razavi S, Bentley S, Johnson C, Findley A, Tolley C, Arbuckle R, Kommineni J, Tyagi N (2020) Social media listening to understand the lived experience of presbyopia: systematic search and content analysis study. J Med Internet Res 22(9):e18306","journal-title":"J Med Internet Res"},{"key":"379_CR23","unstructured":"Bentley S, Findley A, Chiva-Razavi S, Naujoks C, Patalano F, Johnson C, Arbuckle A, Wolffsohn JS (in press) Understanding the visual function symptoms and associated functional impacts of phakic presbyopia. J Patient-Reported Outcome"},{"key":"379_CR24","unstructured":"US Food and Drug Administration (2020) Patient-focused drug development: collecting comprehensive and representative input. Guidance for industry, Food and Drug Administration staff, and other stakeholders. FDA, Maryland"},{"key":"379_CR25","unstructured":"US Food and Drug Administration (2019) Patient-focused drug development: methods to identify what is important to patients. Guidance for Industry, Food and Drug Administration staff, and other stakeholders. Draft guidance. FDA, Maryland"},{"issue":"8","key":"379_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L (2011) Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2\u2014assessing respondent understanding. Value Health 14(8):978\u2013988","journal-title":"Value Health"},{"key":"379_CR27","unstructured":"ATLAS.ti.Scientific Software Development GmbH B, Germany (2013) Atlas.ti.software version 7"},{"issue":"2","key":"379_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77\u2013101","journal-title":"Qual Res Psychol"},{"key":"379_CR29","volume-title":"Analysis of the cognitive interview in questionnaire design","author":"GB Willis","year":"2015","unstructured":"Willis GB (2015) Analysis of the cognitive interview in questionnaire design. Oxford University Press, Oxford"},{"key":"379_CR30","unstructured":"US Food and Drug Administration (2018) Patient-focused drug development guidance public workshop: methods to identify what is important to patients & select, develop or modify fit-for-purpose clinical outcome assessments. Discussion document for Patient-Focused Drug Development Public Workshop on Guidance 3. FDA, Maryland"},{"issue":"63","key":"379_CR31","first-page":"40","volume":"20","author":"I Patel","year":"2007","unstructured":"Patel I, West SK (2007) Presbyopia: prevalence, impact, and interventions. Commun Eye Health 20(63):40","journal-title":"Commun Eye Health"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-021-00379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-021-00379-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-021-00379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T17:13:21Z","timestamp":1635009201000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-021-00379-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1186\/s41687-021-00379-x","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from an Institutional Review Board (IRB), Copernicus Group Independent Review Board (CGIRB; IRB ref: ADE1-18-049), prior to any study related activities in the US, and from Salus IRB (IRB ref: Novartis CUNR844A2001) prior to any study related activities in Germany. In line with ethical requirements for research in France at the time of the research, a letter was submitted to the Conseil National de l'Ordre des M\u00e9decins (CNOM) to notify them of the study procedures and payments to recruiting health professionals. Written and verbal informed consent was obtained from every participant before each interview was conducted and before any other study activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JW is a developer of the original NAVQ and has been engaged with Novartis on other projects and has received honoraria for speaker events, ad boards and other related activities. RA, SB, and AF are employed by Adelphi Values Patient-Centered Outcomes team, which received funding from Novartis Pharma AG to conduct the research described in this manuscript. The Adelphi Values team also work with many other pharmaceutical companies to perform Patient-Centered Outcomes research. CJ was employed by Adelphi Values Patient-Centered Outcomes at the time of the study. SC-R, FP,CN and GS are employed by Novartis Pharma AG. FP and CN own shares in Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}